Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Application of engineered tumor infiltrating lymphocytes (TIL) in pediatric osteosarcoma
Webber, B. R., Largaespada, D. A., Moriarity, B. S., Starr, T. & Weigel, B. J.
V FOUNDATION FOR CANCER RESEARCH
7/15/22 → 7/15/25
Project: Research project
-
Early Detection of Canine Osteosarcoma
Modiano, J., Borgatti, A. M., Rendahl, A., Spector, L. G., Vallera, D. A. & Weigel, B. J.
4/1/22 → 3/31/25
Project: Research project
-
The Immune and Molecular Landscape of Canine Osteosarcoma at the Single-Cell Level
Modiano, J., Borgatti, A. M., Cheng, E. Y., Greengard, E. G., Largaespada, D. A., Murugan, P., Sarver, A. L. & Weigel, B. J.
3/1/22 → 2/29/24
Project: Research project
-
SARC038: A Phase 2 Study of Regorafenib in Combination with Nivolumab in Patients with Refractory orRecurrent Osteosarcoma
2/16/22 → 11/30/23
Project: Research project
-
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis
Weiss, A. R., Dry, S., Maygar, C., Cutler, A., Lary, C. W., Khoo, C., Fergione, J. E., Hounchell, M. M., Glick, K., Browning, M., Choo, S. H., Hawkins, D. S., Lagmay, J., Manalang, M., Skapek, S. X., Weigel, B., Verwys, S. & Federman, N., Sep 2023, In: Pediatric Blood and Cancer. 70, 9, e30466.Research output: Contribution to journal › Article › peer-review
-
Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics
Fox, E., Parsons, D. W. & Weigel, B. J., Sep 2023, In: Pediatric Blood and Cancer. 70, S6, e30563.Research output: Contribution to journal › Article › peer-review
Open Access -
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Moreno, L., Dubois, S. G., Glade Bender, J., Mauguen, A., Bird, N., Buenger, V., Casanova, M., Doz, F., Fox, E., Gore, L., Hawkins, D. S., Izraeli, S., Jones, D. T. W., Kearns, P. R., Molenaar, J. J., Nysom, K., Pfister, S., Reaman, G., Smith, M., Weigel, B., & 5 others , Jun 20 2023, In: Journal of Clinical Oncology. 41, 18, p. 3408-3422 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Pearson, A. D. J., Federico, S., Gatz, S. A., Ortiz, M., Lesa, G., Scobie, N., Gounaris, I., Weiner, S. L., Weigel, B., Unger, T. J., Stewart, E., Smith, M., Slotkin, E. K., Reaman, G., Pappo, A., Nysom, K., Norga, K., McDonough, J., Marshall, L. V., Ludwinski, D., & 21 others , Sep 2023, In: European Journal of Cancer. 190, 112950.Research output: Contribution to journal › Review article › peer-review
Open Access -
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma
Cole, K. A., Ijaz, H., Surrey, L. F., Santi, M., Liu, X., Minard, C. G., Maris, J. M., Voss, S., Reid, J. M., Fox, E. & Weigel, B. J., 2023, (Accepted/In press) In: Cancer.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations